A Study to Assess the Effect of High Fat Meal and Increased Gastric pH on the Bioavailability of an Extended Release Formulation of BMS-663068 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 27, 2016

Primary Completion Date

February 22, 2016

Study Completion Date

February 22, 2016

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG

BMS-663068

Trial Locations (1)

GSK Investigational Site, Austin